Entering text into the input field will update the search result below

Neurocrine Biosciences beats by $0.07, misses on revenue

  • Neurocrine Biosciences (NASDAQ:NBIX): Q1 EPS of -$0.22 beats by $0.07.
  • Revenue of $15M (-24.1% Y/Y) misses by $0.43M.
  • Press Release

Recommended For You

More Trending News

About NBIX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NBIX--
Neurocrine Biosciences, Inc.